Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Allergan Plc (AGN)

Allergan Plc (AGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 58,266,260
  • Shares Outstanding, K 329,002
  • Annual Sales, $ 16,089 M
  • Annual Income, $ -5,271,000 K
  • 60-Month Beta 1.47
  • Price/Sales 3.61
  • Price/Cash Flow 4.80
  • Price/Book 0.99

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate 4.24
  • Number of Estimates 1
  • High Estimate 4.24
  • Low Estimate 4.24
  • Prior Year 3.79
  • Growth Rate Est. (year over year) +11.87%

Price Performance

See More
Period Period Low Period High Performance
1-Month
158.67 +11.62%
on 03/18/20
195.98 -9.63%
on 03/04/20
-13.57 (-7.12%)
since 02/28/20
3-Month
158.67 +11.62%
on 03/18/20
202.21 -12.42%
on 02/12/20
-14.30 (-7.47%)
since 12/27/19
52-Week
114.27 +54.98%
on 06/17/19
202.21 -12.42%
on 02/12/20
+30.69 (+20.96%)
since 03/29/19

Most Recent Stories

More News
Allergan Earns ENERGY STAR® Partner of the Year - Sustained Excellence Award for the Seventh Consecutive Year

Allergan plc (NYSE: AGN) today announced it has received the ENERGY STAR® Partner of the Year Sustained Excellence Award for 2020, marking the seventh consecutive year it has earned ENERGY STAR®'s highest...

AGN : 177.10 (+0.45%)
Medical Mushroom Companies Expand as People Seek New Mental Health Treatments

The search for ways to improve mental health is driving expansion for a variety of companies looking to offer effective solutions, including treatments that are tapping into the power of psychedelic mushrooms....

HLF : 29.16 (+0.97%)
AXSM : 58.83 (+2.17%)
AGN : 177.10 (+0.45%)
JNJ : 131.13 (-1.41%)
SHRM.CN : 0.590 (+19.19%)
Stocks Start the Week by Soaring More Than 3%

Stocks Start the Week by Soaring More Than 3%

NKE : 82.74 (-3.09%)
EXPI : 8.46 (+2.55%)
XEL : 60.30 (-3.61%)
SEDG : 81.88 (+0.29%)
PDCO : 15.29 (-6.43%)
BAH : 68.64 (-3.70%)
AGN : 177.10 (+0.45%)
ATO : 99.23 (-3.49%)
NEM : 45.28 (-2.33%)
SFM : 18.59 (-0.05%)
STNG : 19.12 (-7.50%)
PSX : 53.65 (-0.94%)
UNG : 12.55 (-2.11%)
USO : 4.21 (-0.47%)
UGA : 10.12 (-4.71%)
FB : 166.80 (+0.51%)
JNJ : 131.13 (-1.41%)
RDWR : 21.07 (-2.77%)
UPRO : 27.63 (-4.66%)
TQQQ : 47.64 (-2.78%)
NVDA : 263.60 (-0.75%)
AYX : 95.17 (-0.76%)
Allergan Plc Set to Possibly Pullback After Yesterday's Rally of 1.39%

Allergan Plc (NYSE:AGN) traded in a range yesterday that spanned from a low of $174.31 to a high of $177.33. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $176.59...

AGN : 177.10 (+0.45%)
Hormone Replacement Therapy Market to Reach USD 20.76 Billion by 2026; Increasing Cases of Hormone-Related Disorders to Augment Growth, states Fortune Business Insights(TM)

The global hormone replacement therapy market size is predicted to reach USD 20.76 billion by 2026, exhibiting a CAGR of 6.0% during the forecast period. The increasing cases of hormone-related disorders...

ABBV : 76.19 (+1.26%)
AGN : 177.10 (+0.45%)
AMGN : 202.73 (-2.76%)
LLY : 138.72 (+0.20%)
ENDP : 3.70 (+1.09%)
MKKGY : 20.4000 (+3.24%)
The Allergan Foundation Donates $2.0 Million to Community Organizations on Front-Line of COVID-19 Response

Allergan plc (NYSE: AGN) today announced that The Allergan Foundation has awarded approximately $13 million in charitable grants in 2020 as part of its commitment to providing a lasting and positive impact...

AGN : 177.10 (+0.45%)
Dermatological Therapeutics Market 2016: Emerging Trends and Future Opportunities Till 2022

Global Dermatological Therapeutics basically caters to three problems viz. cosmetics, skin cancer and general conditions such as Acne. Current analysis of the market shows huge demand and a lesser supply,...

AGN : 177.10 (+0.45%)
VRX.TO : 30.80 (-3.33%)
Diabetic Macular Edema Market will Reach at a CAGR of ~ 1.1% from 2017 to 2027

The global diabetic macular edema (DME) market is projected to register a sluggish expansion at 1.1% CAGR through 2027, according to a report by Future Market Insights (FMI). The report estimates the market...

ALIM : 4.00 (+10.80%)
AGN : 177.10 (+0.45%)
BAYRY : 14.4700 (-0.75%)
VRX.TO : 30.80 (-3.33%)
Dermatological Therapeutics Market 2016: Demand, Growth Opportunities and Top Key Players Analysis Report 2022

Global Dermatological Therapeutics basically caters to three problems viz. cosmetics, skin cancer and general conditions such as Acne. Current analysis of the market shows huge demand and a lesser supply,...

AGN : 177.10 (+0.45%)
VRX.TO : 30.80 (-3.33%)
Medical Aesthetics Demand Forecast to rising 9.09% Through 2020-2026

AGN : 177.10 (+0.45%)
ANIK : 28.91 (+1.33%)
HOLX : 35.10 (+0.29%)
SIEN : 1.9900 (-2.45%)
ELOS : 11.00 (unch)
VRX.TO : 30.80 (-3.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Trade AGN with:

Business Summary

Allergan, Inc. is a healthcare company. It focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets. Allergan...

See More

Key Turning Points

2nd Resistance Point 180.96
1st Resistance Point 179.03
Last Price 177.10
1st Support Level 175.16
2nd Support Level 173.22

See More

52-Week High 202.21
Last Price 177.10
Fibonacci 61.8% 168.62
Fibonacci 50% 158.24
Fibonacci 38.2% 147.86
52-Week Low 114.27

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar